{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:49Z","timestamp":1753891909293,"version":"3.41.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Purpose:<\/jats:bold> Studies involving mouse models and human uterine smooth muscle cells have shown that phenylephrine inhibits uterine contractions in non-pregnant mice and human <jats:italic>in vitro<\/jats:italic> cell <jats:italic>via<\/jats:italic> cyclic adenosine monophosphate (cAMP) signaling. However, there has been no limited exploration to date of the effect of phenylephrine on uterine contractions in clinical practice. This study aimed to compare the dose requirement of oxytocin with or without the infusion of prophylactic phenylephrine to prevent post spinal hypotension during cesarean delivery under combined spinal and epidural anesthesia.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This was a double-blinded, single-center, randomized, control study. One hundred and sixty pregnant patients provided informed consent and were randomly allocated to the phenylephrine (phenylephrine infusion) and control (saline infusion) groups. Patients randomized to the phenylephrine group received an intravenous prophylactic phenylephrine infusion at a fixed rate of 0.5\u00a0\u03bcg\/kg\/min. The control group received a saline placebo at the same rate and used the same apparatus for delivery. After neonatal delivery and clamping of the umbilical cord, patients received a standard institutional oxytocin protocol. The primary outcome measure was the total dose of oxytocin administered during CD. Secondary outcomes including the proportion (%) of patients requiring a secondary uterotonic agent and estimated blood loss (EBL) in the first 24\u00a0h after surgery.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The median oxytocin dose administered was significantly higher in the phenylephrine group than in the control group [6.9 \u00b1 2.5 international standardized units (IU) <jats:italic>vs.<\/jats:italic> 5.4 \u00b1 2.4 IU, <jats:italic>p<\/jats:italic> = 0.0004]. The number of patients that required a secondary uterotonic agent was significantly higher in the phenylephrine group than in the control group (24.2% <jats:italic>vs.<\/jats:italic> 9.1%; <jats:italic>p<\/jats:italic> = 0.034). The EBL in the first 24-h postoperatively was similar between the two groups (467 \u00b1 47\u00a0ml <jats:italic>vs.<\/jats:italic> 392 \u00b1 38\u00a0ml; <jats:italic>p<\/jats:italic> = 0.22).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Prophylactic infusion of phenylephrine used to prevent post-spinal hypotension during CD was associated with a higher dose of oxytocin. This has important clinical implications, as the suboptimal use of oxytocin is associated with an increased risk of postpartum hemorrhage and increased maternal morbidity and mortality. Further studies are now needed to confirm these findings.<\/jats:p>","DOI":"10.3389\/fphar.2021.720906","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T22:51:03Z","timestamp":1634770263000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Prophylactic Phenylephrine Increases the Dose Requirement of Oxytocin to Treat Uterine Atony During Cesarean Delivery: A Double-Blinded, Single-Center, Randomized and Placebo-Controlled Trial"],"prefix":"10.3389","volume":"12","author":[{"given":"Yao-Hua","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Dan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jia","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1213\/ANE.0b013e3181e1db21","article-title":"A Double-Blind, Placebo-Controlled Trial of Four Fixed Rate Infusion Regimens of Phenylephrine for Hemodynamic Support during Spinal Anesthesia for Cesarean Delivery","volume":"111","author":"Allen","year":"2010","journal-title":"Anesth. Analg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1213\/ANE.0000000000001905","article-title":"Prophylactic Phenylephrine Infusions to Reduce Severe Spinal Anesthesia Hypotension during Cesarean Delivery in a Resource-Constrained Environment","volume":"125","author":"Bishop","year":"2017","journal-title":"Anesth. Analg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ejphar.2015.11.015","article-title":"The Effects of Female Sexual Hormones on the Expression and Function of \u03b11A- and \u03b11D-adrenoceptor Subtypes in the Late-Pregnant Rat Myometrium","volume":"769","author":"B\u00f3ta","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/bja\/aeq004","article-title":"Minimum Effective Bolus Dose of Oxytocin during Elective Caesarean Delivery","volume":"104","author":"Butwick","year":"2010","journal-title":"Br. J. Anaesth."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/01.AOG.0000142709.04450.bd","article-title":"Oxytocin Requirements at Elective Cesarean Delivery: a Dose-Finding Study","volume":"104","author":"Carvalho","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"11666","DOI":"10.1038\/s41598-018-30094-5","article-title":"Phenylephrine, a Common Cold Remedy Active Ingredient, Suppresses Uterine Contractions through cAMP Signalling","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1213\/ANE.0000000000001658","article-title":"Effect of a High-Rate versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility during Elective Cesarean Delivery: A Prospective Randomized Clinical Trial","volume":"124","author":"Duffield","year":"2017","journal-title":"Anesth. Analg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00404-014-3212-x","article-title":"Update on Best Available Options in Obstetrics Anaesthesia: Perinatal Outcomes, Side Effects and Maternal Satisfaction. Fifteen Years Systematic Literature Review","volume":"290","author":"Gizzo","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/anae.12445","article-title":"Prophylactic Phenylephrine for Caesarean Section under Spinal Anaesthesia: Systematic Review and Meta-Analysis","volume":"69","author":"Heesen","year":"2014","journal-title":"Anaesthesia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/anae.14080","article-title":"International Consensus Statement on the Management of Hypotension with Vasopressors during Caesarean Section under Spinal Anaesthesia","volume":"73","author":"Kinsella","year":"2018","journal-title":"Anaesthesia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/ALN.0000000000000682","article-title":"A Randomized, Double-Blinded Trial of a \"Rule of Threes\" Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery","volume":"123","author":"Kovacheva","year":"2015","journal-title":"Anesthesiology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1213\/ANE.0000000000000781","article-title":"The ED90 of Prophylactic Oxytocin Infusion after Delivery of the Placenta during Cesarean Delivery in Laboring Compared with Nonlaboring Women: an Up-Down Sequential Allocation Dose-Response Study","volume":"121","author":"Lavoie","year":"2015","journal-title":"Anesth. Analg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/ALN.0b013e3181b160a3","article-title":"Placental Transfer and Fetal Metabolic Effects of Phenylephrine and Ephedrine during Spinal Anesthesia for Cesarean Delivery","volume":"111","author":"Ngan Kee","year":"2009","journal-title":"Anesthesiology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/ALN.0000000000000601","article-title":"Randomized Double-Blinded Comparison of Norepinephrine and Phenylephrine for Maintenance of Blood Pressure during Spinal Anesthesia for Cesarean Delivery","volume":"122","author":"Ngan Kee","year":"2015","journal-title":"Anesthesiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/ACO.0b013e328337ffc6","article-title":"Prevention of Maternal Hypotension after Regional Anaesthesia for Caesarean Section","volume":"23","author":"Ngan Kee","year":"2010","journal-title":"Curr. Opin. Anaesthesiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/ACO.0000000000000453","article-title":"The Use of Vasopressors during Spinal Anaesthesia for Caesarean Section","volume":"30","author":"Ngan Kee","year":"2017","journal-title":"Curr. Opin. Anaesthesiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"995","DOI":"10.4103\/ija.IJA_481_19","article-title":"Comparison of Norepinephrine and Phenylephrine Boluses for the Treatment of Hypotension during Spinal Anaesthesia for Caesarean Section - A Randomised Controlled Trial","volume":"63","author":"Puthenveettil","year":"2019","journal-title":"Indian J. Anaesth."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1213\/ANE.0000000000003704","article-title":"Comparison of Intermittent Intravenous Boluses of Phenylephrine and Norepinephrine to Prevent and Treat Spinal-Induced Hypotension in Cesarean Deliveries: Randomized Controlled Trial","volume":"129","author":"Sharkey","year":"2019","journal-title":"Anesth. Analg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"d4661","DOI":"10.1136\/bmj.d4661","article-title":"Oxytocin Bolus versus Oxytocin Bolus and Infusion for Control of Blood Loss at Elective Caesarean Section: Double Blind, Placebo Controlled, Randomised Trial","volume":"343","author":"Sheehan","year":"2011","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1213\/ANE.0000000000004092","article-title":"Dose-Response Study of 4 Weight-Based Phenylephrine Infusion Regimens for Preventing Hypotension during Cesarean Delivery under Combined Spinal-Epidural Anesthesia","volume":"130","author":"Xiao","year":"2020","journal-title":"Anesth. Analg"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.720906\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T22:51:06Z","timestamp":1634770266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.720906\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":20,"alternative-id":["10.3389\/fphar.2021.720906"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.720906","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2021,10,20]]},"article-number":"720906"}}